|Bid||2.8600 x 900|
|Ask||3.3000 x 2200|
|Day's Range||2.9000 - 2.9900|
|52 Week Range||2.7000 - 7.8450|
|Beta (5Y Monthly)||0.47|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 01, 2021 - Nov. 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.17|
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
Shareholders might have noticed that Repro Med Systems, Inc. ( NASDAQ:KRMD ) filed its quarterly result this time last...
CHESTER, N.Y., August 11, 2021--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the second quarter ended June 30, 2021.